Breaking News Instant updates and real-time market news.

10:18
08/12/20
08/12
10:18
08/12/20
10:18

Atlanta Fed Business Inflation Expectations Bus Infl Exp % Yr/Yr data reported

August Atlanta Fed Business Inflation Expectations Bus Infl Exp % Yr/Yr up 1.7% for the year

TODAY'S FREE FLY STORIES

Recommendations
Floor & Decor price target raised to $85 from $80 at Wells Fargo » 06:54
09/18/20
09/18
06:54
09/18/20
06:54
FND

Floor & Decor

$74.60 /

-1.35 (-1.78%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FND Floor & Decor
$74.60 /

-1.35 (-1.78%)

FND Floor & Decor
$74.60 /

-1.35 (-1.78%)

08/07/20 Wedbush
Flooring companies not excluded from tariffs under USTR order, says Wedbush
08/03/20 Loop Capital
Floor & Decor price target raised to $70 from $40 at Loop Capital
08/03/20 BofA
Floor & Decor upgraded to Buy from Neutral at BofA
08/03/20 BofA
Floor & Decor upgraded to Buy from Neutral at BofA
FND Floor & Decor
$74.60 /

-1.35 (-1.78%)

  • 11
    Aug
  • 20
    May
  • 15
    Nov
FND Floor & Decor
$74.60 /

-1.35 (-1.78%)

Hot Stocks
Piedmont Lithium trading halted, news pending  06:54
09/18/20
09/18
06:54
09/18/20
06:54
PLL

Piedmont Lithium

$10.97 /

+2.6 (+31.06%)

 
ShowHide Related Items >><<
PLL Piedmont Lithium
$10.97 /

+2.6 (+31.06%)

PLL Piedmont Lithium
$10.97 /

+2.6 (+31.06%)

05/27/20 Roth Capital
Piedmont Lithium price target lowered to $20 from $28 at Roth Capital
  • 09
    Jun
Recommendations
Societe Generale ups AstraZeneca target, sees earnings tripling in five years » 06:52
09/18/20
09/18
06:52
09/18/20
06:52
AZN

AstraZeneca

$55.93 /

+0.79 (+1.43%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
09/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'underappreciated' Entasis at Overweight
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

Recommendations
Canada Goose's China opportunity underappreciated by market, says UBS » 06:50
09/18/20
09/18
06:50
09/18/20
06:50
GOOS

Canada Goose

$28.74 /

+0.225 (+0.79%)

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOS Canada Goose
$28.74 /

+0.225 (+0.79%)

GOOS Canada Goose
$28.74 /

+0.225 (+0.79%)

09/10/20 Exane BNP Paribas
Canada Goose initiated with an Underperform at Exane BNP Paribas
08/12/20 RBC Capital
Canada Goose price target lowered to C$43 from C$47 at RBC Capital
08/12/20 Baird
Canada Goose attractive for patient investors, says Baird
08/12/20 RBC Capital
Canada Goose price target lowered to C$43 from C$47 at RBC Capital
GOOS Canada Goose
$28.74 /

+0.225 (+0.79%)

GOOS Canada Goose
$28.74 /

+0.225 (+0.79%)

GOOS Canada Goose
$28.74 /

+0.225 (+0.79%)

GOOS Canada Goose
$28.74 /

+0.225 (+0.79%)

Upgrade
Morgan Stanley upgrades II-VI to Overweight on diversification » 06:50
09/18/20
09/18
06:50
09/18/20
06:50
IIVI

II-VI

$37.88 /

-0.72 (-1.87%)

, LITE

Lumentum

$70.80 /

-0.57 (-0.80%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IIVI II-VI
$37.88 /

-0.72 (-1.87%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

IIVI II-VI
$37.88 /

-0.72 (-1.87%)

05:06 Today Morgan Stanley
II-VI upgraded to Overweight from Equal Weight at Morgan Stanley
09/08/20 Citi
II-VI initiated with a Buy at Citi
09/04/20 Morgan Stanley
Ciena price target lowered to $46 from $50 at Morgan Stanley
08/14/20 DA Davidson
II-VI price target raised to $60 from $45 at DA Davidson
LITE Lumentum
$70.80 /

-0.57 (-0.80%)

09/16/20 Barclays
Lumentum price target lowered to $90 from $105 at Barclays
09/14/20 Susquehanna
Lumentum weakness a buying opportunity, says Susquehanna
09/10/20 Northland
Next gen ROADMs potential not priced into Lumentum shares, says Northland
09/04/20 Morgan Stanley
Ciena price target lowered to $46 from $50 at Morgan Stanley
IIVI II-VI
$37.88 /

-0.72 (-1.87%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

  • 02
    Jul
IIVI II-VI
$37.88 /

-0.72 (-1.87%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

IIVI II-VI
$37.88 /

-0.72 (-1.87%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

Hot Stocks
Astellas Pharma, Seattle Genetics announce Padcev trial meets primary endpoint » 06:50
09/18/20
09/18
06:50
09/18/20
06:50
ALPMY

Astellas Pharma

$0.00 /

+ (+0.00%)

, SGEN

Seattle Genetics

$175.77 /

-0.995 (-0.56%)

Astellas Pharma (ALPMY)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

SGEN Seattle Genetics
$175.77 /

-0.995 (-0.56%)

ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy on raised PADCEV estimates at Goldman Sachs
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy from Neutral at Goldman Sachs
01/23/20 Morgan Stanley
Astellas Pharma resumed with an Overweight at Morgan Stanley
12/05/19 JPMorgan
Audentes Therapeutics downgraded to Neutral from Overweight at JPMorgan
SGEN Seattle Genetics
$175.77 /

-0.995 (-0.56%)

04:57 Today Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/15/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
SGEN Seattle Genetics
$175.77 /

-0.995 (-0.56%)

SGEN Seattle Genetics
$175.77 /

-0.995 (-0.56%)

Hot Stocks
Merck, AZN announce 'positive' five-year follow-up data from Phase 3 SOLO-1 » 06:50
09/18/20
09/18
06:50
09/18/20
06:50
MRK

Merck

$85.65 /

+0.01 (+0.01%)

, AZN

AstraZeneca

$55.93 /

+0.79 (+1.43%)

AstraZeneca (AZN) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
09/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'underappreciated' Entasis at Overweight
MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

Upgrade
JPMorgan upgrades Alstom to Overweight on upside from BT deal » 06:49
09/18/20
09/18
06:49
09/18/20
06:49
ALSMY

Alstom

$0.00 /

+ (+0.00%)

JPMorgan analyst Akash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALSMY Alstom
$0.00 /

+ (+0.00%)

ALSMY Alstom
$0.00 /

+ (+0.00%)

04:45 Today JPMorgan
Alstom upgraded to Overweight from Neutral at JPMorgan
08/03/20 Commerzbank
Alstom initiated with a Buy at Commerzbank
07/20/20 JPMorgan
Alstom price target raised to EUR 44 from EUR 38 at JPMorgan
07/17/20 UBS
Alstom price target raised to EUR 55 from EUR 48 at UBS
ALSMY Alstom
$0.00 /

+ (+0.00%)

Periodicals
Belgium-based Ontex looks to buy Domtar's personal-care unit, Bloomberg reports » 06:48
09/18/20
09/18
06:48
09/18/20
06:48
UFS

Domtar

$28.07 /

+1.915 (+7.32%)

Belgium-based personal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UFS Domtar
$28.07 /

+1.915 (+7.32%)

UFS Domtar
$28.07 /

+1.915 (+7.32%)

08/14/20
Fly Intel: Top five analyst upgrades
08/14/20 Citi
Domtar upgraded to Buy from Neutral at Citi
08/13/20 Citi
Domtar upgraded to Buy from Neutral at Citi
08/10/20 RBC Capital
Domtar price target raised to $26 from $21 at RBC Capital
UFS Domtar
$28.07 /

+1.915 (+7.32%)

UFS Domtar
$28.07 /

+1.915 (+7.32%)

Hot Stocks
Seattle Genetics, Astellas Pharma: Phase 3 trial of PADCEV met primary endpoint » 06:47
09/18/20
09/18
06:47
09/18/20
06:47
SGEN

Seattle Genetics

$175.77 /

-0.995 (-0.56%)

, ALPMY

Astellas Pharma

$0.00 /

+ (+0.00%)

Seattle Genetics (SGEN)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGEN Seattle Genetics
$175.77 /

-0.995 (-0.56%)

ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

SGEN Seattle Genetics
$175.77 /

-0.995 (-0.56%)

04:57 Today Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/15/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy on raised PADCEV estimates at Goldman Sachs
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy from Neutral at Goldman Sachs
01/23/20 Morgan Stanley
Astellas Pharma resumed with an Overweight at Morgan Stanley
12/05/19 JPMorgan
Audentes Therapeutics downgraded to Neutral from Overweight at JPMorgan
SGEN Seattle Genetics
$175.77 /

-0.995 (-0.56%)

SGEN Seattle Genetics
$175.77 /

-0.995 (-0.56%)

Initiation
Pennon Group reinstated with an Outperform at RBC Capital » 06:46
09/18/20
09/18
06:46
09/18/20
06:46
PEGRF

Pennon Group

$0.00 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PEGRF Pennon Group
$0.00 /

+ (+0.00%)

11/27/19 Citi
Pennon Group downgraded to Neutral from Buy at Citi
10/10/19 Barclays
Pennon Group upgraded to Overweight from Equal Weight at Barclays
09/30/19 Deutsche Bank
Pennon Group upgraded to Buy from Hold at Deutsche Bank
Upgrade
Kerry Group upgraded to Overweight from Equal Weight at Morgan Stanley » 06:46
09/18/20
09/18
06:46
09/18/20
06:46
KRYAY

Kerry Group

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRYAY Kerry Group
$0.00 /

+ (+0.00%)

08/04/20 Berenberg
Kerry Group price target raised to EUR 128 from EUR 122 at Berenberg
08/03/20 JPMorgan
Kerry Group price target raised to EUR 109 from EUR 97 at JPMorgan
08/03/20 Deutsche Bank
Kerry Group volume trends 'rapidly improving,' says Deutsche Bank
08/03/20 Credit Suisse
Kerry Group Q2 impacted by lower out-of-home consumption, says Credit Suisse
Upgrade
Elior upgraded to Buy on 'significant discount' at Berenberg » 06:42
09/18/20
09/18
06:42
09/18/20
06:42
ELROF

Elior Group

/

+

Berenberg analyst Annabel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELROF Elior Group
/

+

05:05 Today Berenberg
Elior Group upgraded to Buy from Hold at Berenberg
08/17/20 Berenberg
Elior Group price target lowered to EUR 5.50 from EUR 6 at Berenberg
08/12/20 UBS
Elior Group price target raised to EUR 6 from EUR 5.80 at UBS
07/06/20 Bryan Garnier
Elior Group downgraded to Sell from Neutral at Bryan Garnier
Upgrade
Morgan Stanley ups SunPower to Equal Weight after manufacturing unit spinoff » 06:42
09/18/20
09/18
06:42
09/18/20
06:42
SPWR

SunPower

$9.90 /

-0.8 (-7.48%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPWR SunPower
$9.90 /

-0.8 (-7.48%)

SPWR SunPower
$9.90 /

-0.8 (-7.48%)

05:07 Today Morgan Stanley
SunPower upgraded to Equal Weight from Underweight at Morgan Stanley
09/11/20 Baird
Baird upgrades 'simpler' SunPower to Outperform with $13 target
09/11/20 Baird
SunPower upgraded to Outperform from Neutral at Baird
07/14/20 Spin-Off Research
SunPower downgraded to Sell from Hold at Spin-Off Research
SPWR SunPower
$9.90 /

-0.8 (-7.48%)

  • 21
    Nov
SPWR SunPower
$9.90 /

-0.8 (-7.48%)

SPWR SunPower
$9.90 /

-0.8 (-7.48%)

Hot Stocks
AstraZeneca reports Lynparza PFS benefit vs. placebo during ESMO presentation » 06:42
09/18/20
09/18
06:42
09/18/20
06:42
AZN

AstraZeneca

$55.93 /

+0.79 (+1.43%)

, MRK

Merck

$85.65 /

+0.01 (+0.01%)

AstraZeneca (AZN) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
09/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'underappreciated' Entasis at Overweight
MRK Merck
$85.65 /

+0.01 (+0.01%)

09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

Hot Stocks
Alkermes presents ARTISTRY-1 data, expands monotherapy melanoma cohort » 06:41
09/18/20
09/18
06:41
09/18/20
06:41
ALKS

Alkermes

$18.45 /

+0.57 (+3.19%)

Alkermes said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALKS Alkermes
$18.45 /

+0.57 (+3.19%)

ALKS Alkermes
$18.45 /

+0.57 (+3.19%)

08/21/20 Mizuho
Alkermes comments on FDA panel may pressure shares, says Mizuho
07/30/20 Mizuho
Alkermes price target raised to $19 from $16 at Mizuho
07/30/20 Goldman Sachs
Alkermes downgraded to Sell from Neutral at Goldman Sachs
06/19/20 Piper Sandler
Biogen price target lowered to $260 from $307 at Piper Sandler
ALKS Alkermes
$18.45 /

+0.57 (+3.19%)

Upgrade
CIBC upgrades Winpak to Outperformer on muted COVID impact » 06:40
09/18/20
09/18
06:40
09/18/20
06:40
WIPKF

Winpak

$0.00 /

+ (+0.00%)

CIBC analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WIPKF Winpak
$0.00 /

+ (+0.00%)

05:16 Today CIBC
Winpak upgraded to Outperformer from Neutral at CIBC
05/06/20 TD Securities
Winpak price target raised to C$48 from C$45 at TD Securities
05/06/20 Scotiabank
Winpak price target raised to C$53 from C$51 at Scotiabank
05/06/20 RBC Capital
Winpak price target lowered to C$45 from C$46 at RBC Capital
Downgrade
Novocure downgraded to Equal Weight at Wells Fargo on valuation » 06:37
09/18/20
09/18
06:37
09/18/20
06:37
NVCR

Novocure

$108.96 /

+1.71 (+1.59%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVCR Novocure
$108.96 /

+1.71 (+1.59%)

NVCR Novocure
$108.96 /

+1.71 (+1.59%)

05:18 Today Wells Fargo
Novocure downgraded to Equal Weight from Overweight at Wells Fargo
09/17/20
Fly Intel: Top five analyst downgrades
09/17/20 Truist
Novocure downgraded to Hold from Buy at Truist
09/17/20 Truist
Novocure downgraded to Hold from Buy at Truist
NVCR Novocure
$108.96 /

+1.71 (+1.59%)

NVCR Novocure
$108.96 /

+1.71 (+1.59%)

Upgrade
Fox Factory upgraded to Buy following pullback at Stifel » 06:36
09/18/20
09/18
06:36
09/18/20
06:36
FOXF

Fox Factory

$75.56 /

+2.36 (+3.22%)

, F

Ford

$7.29 /

+0.26 (+3.70%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOXF Fox Factory
$75.56 /

+2.36 (+3.22%)

F Ford
$7.29 /

+0.26 (+3.70%)

FOXF Fox Factory
$75.56 /

+2.36 (+3.22%)

09/17/20 Stifel
Fox Factory upgraded to Buy from Hold at Stifel
07/15/20 Jefferies
Jefferies says Fox Factory absence on Bronco doesn't impair competitive position
07/14/20 Baird
Fox Factory down on Ford picking Bilstein for Bronco shocks, says Baird
06/16/20 CJS Securities
Fox Factory downgraded to Market Perform from Outperform at CJS Securities
F Ford
$7.29 /

+0.26 (+3.70%)

09/08/20
Fly Intel: Top five analyst upgrades
09/08/20 Evercore ISI
Evercore ISI giving Ford 'benefit of the doubt,' upgrades to In Line
09/08/20 Evercore ISI
Ford upgraded to In Line from Underperform at Evercore ISI
08/17/20 Credit Suisse
Credit Suisse say Ford, GM can fund EV development through strong trucking
FOXF Fox Factory
$75.56 /

+2.36 (+3.22%)

F Ford
$7.29 /

+0.26 (+3.70%)

  • 18
    Jun
F Ford
$7.29 /

+0.26 (+3.70%)

FOXF Fox Factory
$75.56 /

+2.36 (+3.22%)

F Ford
$7.29 /

+0.26 (+3.70%)

F Ford
$7.29 /

+0.26 (+3.70%)

Recommendations
Quanta Services price target raised to $60 from $45 at KeyBanc » 06:35
09/18/20
09/18
06:35
09/18/20
06:35
PWR

Quanta Services

$52.62 /

+0.095 (+0.18%)

KeyBanc analyst Sean…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PWR Quanta Services
$52.62 /

+0.095 (+0.18%)

PWR Quanta Services
$52.62 /

+0.095 (+0.18%)

08/07/20 Citi
Quanta Services price target raised to $55 from $50 at Citi
07/17/20 B. Riley FBR
Quanta Services price target raised to $47 from $42 at B. Riley FBR
07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
06/23/20 Stifel
Quanta Services price target raised to $50 from $46 at Stifel
PWR Quanta Services
$52.62 /

+0.095 (+0.18%)

PWR Quanta Services
$52.62 /

+0.095 (+0.18%)

PWR Quanta Services
$52.62 /

+0.095 (+0.18%)

PWR Quanta Services
$52.62 /

+0.095 (+0.18%)

Hot Stocks
AstraZeneca presents updated Imfinzi results from PACIFIC trial at ESMO » 06:35
09/18/20
09/18
06:35
09/18/20
06:35
AZN

AstraZeneca

$55.93 /

+0.79 (+1.43%)

Updated results from the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
09/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'underappreciated' Entasis at Overweight
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

Hot Stocks
Pivotal Investment Corp. II, XL Fleet enter definitive merger agreement » 06:35
09/18/20
09/18
06:35
09/18/20
06:35
PIC

Pivotal Investment Corp. II

$10.57 /

-0.03 (-0.28%)

XL Fleet and Pivotal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Nike price target raised to $132 from $118 at Barclays » 06:34
09/18/20
09/18
06:34
09/18/20
06:34
NKE

Nike

$116.36 /

-2.24 (-1.89%)

Barclays analyst Adrienne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$116.36 /

-2.24 (-1.89%)

NKE Nike
$116.36 /

-2.24 (-1.89%)

09/16/20 Piper Sandler
Nike price target raised to $130 from $112 at Piper Sandler
09/15/20 BTIG
Nike price target raised to $140 from $117 at BTIG
09/15/20 Deutsche Bank
Nike price target raised to $107 from $87 at Deutsche Bank
09/14/20 JPMorgan
Nike price target raised to $136 from $118 at JPMorgan
NKE Nike
$116.36 /

-2.24 (-1.89%)

NKE Nike
$116.36 /

-2.24 (-1.89%)

NKE Nike
$116.36 /

-2.24 (-1.89%)

NKE Nike
$116.36 /

-2.24 (-1.89%)

Upgrade
Stifel upgrades Dave & Buster's to Buy, calls pullback a chance to 'level up' » 06:33
09/18/20
09/18
06:33
09/18/20
06:33
PLAY

Dave & Buster's

$14.13 /

-4.99 (-26.10%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

04:47 Today Stifel
Dave & Buster's upgraded to Buy from Hold at Stifel
04:46 Today Raymond James
Dave & Buster's upgraded to Outperform from Market Perform at Raymond James
09/17/20 Truist
Truist says Dave & Buster's dip on 'unfounded' bankruptcy worries an opportunity
09/11/20 BMO Capital
Dave & Buster's price target raised to $17 from $15 at BMO Capital
PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

  • 04
    May
PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

Recommendations
Spirit Airlines price target raised to $24 from $18 at Barclays » 06:32
09/18/20
09/18
06:32
09/18/20
06:32
SAVE

Spirit Airlines

$18.10 /

-0.46 (-2.48%)

Barclays analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAVE Spirit Airlines
$18.10 /

-0.46 (-2.48%)

SAVE Spirit Airlines
$18.10 /

-0.46 (-2.48%)

07/09/20 Citi
Citi sees expectations for corporate travel rebound all but evaporating
06/29/20 Goldman Sachs
Spirit Airlines price target raised to $20 from $15 at Goldman Sachs
06/17/20
Fly Intel: Top five analyst initiations
06/17/20 Seaport Global
Spirit Airlines initiated with a Buy at Seaport Global
SAVE Spirit Airlines
$18.10 /

-0.46 (-2.48%)

  • 08
    May
SAVE Spirit Airlines
$18.10 /

-0.46 (-2.48%)

SAVE Spirit Airlines
$18.10 /

-0.46 (-2.48%)

SAVE Spirit Airlines
$18.10 /

-0.46 (-2.48%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.